Author:
Lankarani Kamran Bagheri,Honarvar Behnam,Keshani Parisa,Raeisi Shahraki Hadi
Abstract
Abstract
This study aimed to determine the risk factors related to regression and progression of metabolic syndrome, in a 4-year cohort study. A total of 540 individuals (≥ 18 years old) participated in both phase of the study. Participants were categorized into 3 categories of regressed, progressed and unchanged metabolic syndrome (MetS). Demographic, anthropometric and biochemical parameters were assessed for each individual in both phase. Variables differences (delta: Δ) between the two phase of study were calculated. Unchanged group was considered as baseline category. Based on IDF, MetS had been regressed and progressed in 42 participants (7.7%) and 112 (20.7%) participants respectively, in the second phase. More than 47% of people, whose MetS regressed, experienced also NAFLD regression. Results of multiple variable analysis revealed that increased age, positive Δ-TG, and Δ-FBS, significantly increased the odds of MetS progression based on IDF and ATP III definitions, while negative Δ-HDL and Δ-neutrophil to lymph ration increased the odds of progression. On the other hand, negative Δ-TG and positive Δ-HDL significantly increased the odds of Mets regression based of both IDF and ATP III. Management of hypertriglyceridemia, hyperglycemia, and HDL is a critical, non-invasive and accessible approach to change the trend of MetS.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Saklayen, M. G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 20(2), 12 (2018).
2. Punthakee, Z., Goldenberg, R. & Katz, P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can. J. Diabetes 42, S10–S15 (2018).
3. Eckel, R. H., Grundy, S. M. & Zimmet, P. Z. The metabolic syndrome. The Lancet. 365(9468), 1415–1428 (2005).
4. Ľudmila, P., František, B. & Paralič, J. Data analytics for metabolic syndrome diagnostics. World Congress Med. Phys. Biomed. Eng. 2018, 311–314 (2018).
5. Mazloomzadeh, S. & Rashidi Khazaghi, Z. The prevalence of metabolic syndrome in Iran: a systematic review and meta-analysis. Iran J Public Health. 47(4), 473–480 (2018).